Neuberger Berman Group’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-241,846
| Closed | -$2.3M | – | 1811 |
|
|
2023
Q2 | $2.3M | Buy |
241,846
+58,831
| +32% | +$561K | ﹤0.01% | 1055 |
|
|
2023
Q1 | $2.01M | Buy |
183,015
+16,637
| +10% | +$183K | ﹤0.01% | 1084 |
|
|
2022
Q4 | $2.46M | Buy |
166,378
+34,399
| +26% | +$509K | ﹤0.01% | 1027 |
|
|
2022
Q3 | $2.52M | Sell |
131,979
-4,745
| -3% | -$90.7K | ﹤0.01% | 1029 |
|
|
2022
Q2 | $2.91M | Buy |
136,724
+7,448
| +6% | +$159K | ﹤0.01% | 1031 |
|
|
2022
Q1 | $2.49M | Buy |
129,276
+7,179
| +6% | +$138K | ﹤0.01% | 1120 |
|
|
2021
Q4 | $2.53M | Buy |
122,097
+10
| +0% | +$207 | ﹤0.01% | 1136 |
|
|
2021
Q3 | $2.92M | Buy |
122,087
+871
| +0.7% | +$20.8K | ﹤0.01% | 1078 |
|
|
2021
Q2 | $3.3M | Buy |
121,216
+1,546
| +1% | +$42.1K | ﹤0.01% | 1062 |
|
|
2021
Q1 | $3.46M | Buy |
+119,670
| New | +$3.46M | ﹤0.01% | 1034 |
|